Southampton scientists working to improve survival for cancer patients have identified a key characteristic of the disease ...
Cancer Research UK's executive director of research and innovation, Iain Foulkes, said the study was an "exciting development ...
((SL Advertiser)) To learn more about the Fibroblast Plasma Pen and other services offered at Pleasantly Plasma, call 480-980 ...
FibroBiologics, Inc. (Nasdaq: FBLG) announced the successful closure of the second $5 million tranche of financing as part of its Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD., an ...
((SL Advertiser)) To learn more about the Fibroblast Plasma Pen and other services offered at Pleasantly Plasma, call 480-980 ...
Southampton scientists trying to improve survival for cancer patients have identified a characteristic of the disease that could make treatment ...
The January 10, 2017, article by Nogova et al, entitled “Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback